Sr. Director and Scientific Lead; Pharmacokinetics, Pharmacodynamics and Drug Metabolism (PPDM) @ Merck (May 2009 - May 2012)
Senior Director, Clinical PK and PD and DMPK Functional Area Operations Lead @ Merck (January 2008 - April 2009)
Director, Clinical PK and PD @ Merck (June 2006 - December 2007)
Associate Director, Pharmacokinetics and Biopharmaceutics @ Merck (October 2003 - May 2006)
Research Fellow @ Merck (February 2001 - September 2003)
Senior Research Pharmacokineticist @ Merck (November 1996 - January 2001)
Nancy Agrawal Education
University of Michigan
PhD (Chemical Engineering)
1994-1996
University of Michigan
MS (Chemical Engineering)
1990-1994
Kansas State University
BS (Chemical Engineering)
1986-1990
Nancy Agrawal Skills
ADME
Biomarker Discovery
Biomarkers
Biotechnology
Clinical Development
Clinical Pharmacology
DMPK
Drug Development
Drug Discovery
Drug Metabolism
IND
PK/PD
Pharmaceutical Industry
Pharmacodynamics
Pharmacokinetics
Regulatory Submissions
Small Molecules
Biopharmaceutics
Forms
Data Analysis
Business Development
Healthcare
Operations
Marketing
Healthcare Management
Nancy Agrawal Summary
Nancy Agrawal, based in United States, is currently a Executive Vice President, Preclinical Development at Atea Pharmaceuticals, Inc. Nancy Agrawal brings experience from previous roles at Merck. Nancy Agrawal holds a 1994 - 1996 PhD in Chemical Engineering @ University of Michigan. With a robust skill set that includes ADME, Biomarker Discovery, Biomarkers, Biotechnology, Clinical Development and more. Nancy Agrawal has 2 emails on RocketReach.
Looking for a different Nancy Agrawal?
Find contact details for 700 million professionals.